There has been a renewed interest in PCT during the COVID-19 pandemic, where patients are presenting with raised systemic inflammatory markers (e.g., CRP and white cell count (WCC)) independent of bacterial infection. The gene discussed is CALCA; the disease is bacterial infectious disease.